Proteoglycans in health and disease: new concepts for heparanase function in tumor progression and metastasis.
about
LRP-1: a checkpoint for the extracellular matrix proteolysisSulfated hexasaccharides attenuate metastasis by inhibition of P-selectin and heparanaseInvolvement of heparanase in atherosclerosis and other vessel wall pathologiesHeparan Sulfate Proteoglycans Regulate Fgf Signaling and Cell Polarity during Collective Cell Migration.PG545, a heparan sulfate mimetic, reduces heparanase expression in vivo, blocks spontaneous metastases and enhances overall survival in the 4T1 breast carcinoma modelInsights into the key roles of proteoglycans in breast cancer biology and translational medicineFibroblast growth factors as tissue repair and regeneration therapeutics.Fibroblast EXT1-levels influence tumor cell proliferation and migration in composite spheroidsAn artificial miRNA against HPSE suppresses melanoma invasion properties, correlating with a down-regulation of chemokines and MAPK phosphorylation.Expression of heparanase in soft tissue sarcomas of adults.Conformational changes of 1-4-glucopyranosyl residues of a sulfated C-C linked hexasaccharideAssessment of Heparanase-Mediated Angiogenesis Using Microvascular Endothelial Cells: Identification of λ-Carrageenan Derivative as a Potent Anti Angiogenic AgentHeparanase cooperates with Ras to drive breast and skin tumorigenesisHeparanase enhances myeloma progression via CXCL10 downregulation.Proteoglycans in health and disease: novel regulatory signaling mechanisms evoked by the small leucine-rich proteoglycansElevated urine heparanase levels are associated with proteinuria and decreased renal allograft functionMYCN-dependent expression of sulfatase-2 regulates neuroblastoma cell survival.Clinical significance of heparanase splice variant (t5) in renal cell carcinoma: evaluation by a novel t5-specific monoclonal antibodyPG545, a dual heparanase and angiogenesis inhibitor, induces potent anti-tumour and anti-metastatic efficacy in preclinical modelsHeparanase plays a dual role in driving hepatocyte growth factor (HGF) signaling by enhancing HGF expression and activitySST0001, a chemically modified heparin, inhibits myeloma growth and angiogenesis via disruption of the heparanase/syndecan-1 axis.Synthesis of a pseudo-disaccharide library and its application to the characterisation of the heparanase catalytic siteIn vitro and ex vivo evaluation of a multi-epitope heparinase vaccine for various malignancies.DNA methylation of heparanase promoter influences its expression and associated with the progression of human breast cancerHeparanase-mediated loss of nuclear syndecan-1 enhances histone acetyltransferase (HAT) activity to promote expression of genes that drive an aggressive tumor phenotypeAgrin and perlecan mediate tumorigenic processes in oral squamous cell carcinoma.Heparan sulfate differences in rheumatoid arthritis versus healthy seraInvolvement of Heparanase in Empyema: Implication for Novel Therapeutic ApproachesSuramin inhibits cell proliferation in ovarian and cervical cancer by downregulating heparanase expressionThe heparan sulfate mimetic PG545 interferes with Wnt/β-catenin signaling and significantly suppresses pancreatic tumorigenesis alone and in combination with gemcitabineProstaglandins in cancer cell adhesion, migration, and invasionHeparanase induces signal transducer and activator of transcription (STAT) protein phosphorylation: preclinical and clinical significance in head and neck cancerHeparanase Enhances Tumor Growth and Chemoresistance by Promoting AutophagyOverexpression of heparanase multiple antigenic peptide 2 is associated with poor prognosis in gastric cancer: Potential for therapySignificance of heparanase in cancer and inflammation.Deciphering mode of action of heparanase using structurally defined oligosaccharides.Elevated heparanase expression is associated with poor prognosis in breast cancer: a study based on systematic review and TCGA data.Heparan sulfate mimetic PG545-mediated antilymphoma effects require TLR9-dependent NK cell activationHeparanase enhances the insulin receptor signaling pathway to activate extracellular signal-regulated kinase in multiple myeloma.Bioengineered heparins and heparan sulfates.
P2860
Q21285122-E4833303-1E6A-4C8E-B6EF-1DD5CDBFA49AQ24605311-A5560C3C-A9EF-46EF-A447-97F63C8051F8Q27025052-EF08A847-9847-4D75-AD3C-80E95AB33905Q27321298-EDEDBD46-44C5-47BF-9512-DEFF30CF1D8CQ27327191-49333788-D567-4E90-A64B-80FEB69F0234Q28085548-1606C202-263F-40F3-B95C-EA0E193B4DC7Q28272364-CDD899B2-A49A-4C8E-8883-BDAD29D84BCEQ28728778-2A25AF20-33D1-45BA-96C2-0D37BF05F6C8Q31066444-694DFC4E-C2B2-45AD-B1B0-9B75DC83A7ADQ33634228-12BB1742-4116-4224-A446-0ABF7F15A920Q33654719-3E637952-1451-499C-81B0-5D3E4EF3F4C5Q33744134-DE6B0FE1-C98B-4BB3-A5DD-305FE449836DQ34052534-058ECE8B-593A-43AD-92E5-4D48BD5473C8Q34289445-EE318BCA-BCD3-470A-A6F5-7DDB1F592AC2Q34398188-1427F084-21AF-4F88-A6B1-5F61B4A77BE3Q34426913-AFB7BE95-F6CE-4213-A11E-23DD3ABFE20EQ34438510-E9B33E15-4764-454A-BCE9-3218F7E08B7CQ34516760-23A61F93-EA9F-43CD-B07A-8063DC1C216DQ34627931-E6C858C5-98E6-498D-A874-5D473D23514BQ34675956-4B1CF70B-F42F-4A8C-83F5-41FB3189AD1AQ34694466-0AD2A52A-7A2F-423A-87CE-36F8D97FB588Q35049594-7A69D5F9-94C3-420B-820C-54F20C35D8C9Q35051712-F64D25EB-A169-47A4-8F41-4B3F27EF7FD0Q35121612-0DF06730-EACD-4D48-94CF-AED4AD2E593CQ35182839-DC9229D0-91F4-4EA8-96B6-92B0DFD33BF2Q35519929-50E6C554-AC68-4878-9680-0EAFBF88AFACQ35531571-C996E39A-2D49-48AA-A7F4-C4F721B8A95CQ35636604-72715EDF-A94E-4B17-B4CF-CB5CF705C883Q35686336-D79837EE-D835-45D2-825B-DA93C738D671Q35741596-BE98E349-870B-4D2E-A169-3A73DA2DABD3Q35821653-37BAE5F4-465D-4B10-B039-7655F4C895CAQ35838889-07BB45C8-553D-462D-97CA-28E58B1262E4Q36070533-5394DBC3-D8FD-4D5A-A4B9-D616162F2CEBQ36099320-3E6822DB-D839-4E84-8F90-02FE6EB65BDBQ36101233-17494E1C-B664-4B3C-BC2F-D9CCE2FD8B7BQ36298538-C76A7408-861E-4006-9EAF-9AACA8FAE3E8Q36339725-9554FA8E-316C-4429-9789-99A4461A6692Q36430711-9B3DFCEA-177C-4BF5-9389-C6FFCD973335Q36436089-EC2C7F28-DEBF-4E92-867D-056B2946FB66Q36578686-09C07C04-2EB3-460C-8274-A028FEF31E9B
P2860
Proteoglycans in health and disease: new concepts for heparanase function in tumor progression and metastasis.
description
2010 nî lūn-bûn
@nan
2010 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Proteoglycans in health and di ...... or progression and metastasis.
@ast
Proteoglycans in health and di ...... or progression and metastasis.
@en
Proteoglycans in health and di ...... or progression and metastasis.
@nl
type
label
Proteoglycans in health and di ...... or progression and metastasis.
@ast
Proteoglycans in health and di ...... or progression and metastasis.
@en
Proteoglycans in health and di ...... or progression and metastasis.
@nl
prefLabel
Proteoglycans in health and di ...... or progression and metastasis.
@ast
Proteoglycans in health and di ...... or progression and metastasis.
@en
Proteoglycans in health and di ...... or progression and metastasis.
@nl
P2093
P2860
P1433
P1476
Proteoglycans in health and di ...... or progression and metastasis.
@en
P2093
Ilana Dowek
Israel Vlodavsky
Ralph D Sanderson
Uri Barash
Victoria Cohen-Kaplan
P2860
P304
P356
10.1111/J.1742-4658.2010.07799.X
P407
P577
2010-08-31T00:00:00Z